Close

Allergan (AGN), Medicines360 Announce Publication of New Same-Day STI Testing Data

Go back to Allergan (AGN), Medicines360 Announce Publication of New Same-Day STI Testing Data

Medicines360 and Allergan Announce Study Publication Evaluating Pelvic Infection Risk Following Same-Day Sexually Transmitted Infection Testing and LILETTA (levonorgestrel-releasing intrauterine syste

November 16, 2016 8:00 AM EST

SAN FRANCISCO and DUBLIN, Nov. 16, 2016 /PRNewswire/ -- Medicines360, a nonprofit global women's health pharmaceutical company, and Allergan, plc (NYSE: AGN), a leading global pharmaceutical company, today announced the publication of, "A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement" in the November, 2016 medical journal, American Journal of Obstetrics &... More